ArticlePDF Available

The Anti-Endometriotic Effect of Cyperi Rhizoma Extract, Inhibiting Cell Adhesion and the Expression of Pain-Related Factors through Akt and NF-kB Pathways

MDPI
Medicina
Authors:

Abstract and Figures

Rhizomes of Cyperus rotundus have been widely used as a traditional medicine in Asia for the treatment of gynecological diseases. However, there is no scientific evidence demonstrating the effect of C. rotundus rhizomes on endometriosis, which is characterized by the adhesion of endometrial tissues outside the uterus, resulting in chronic and severe pelvic pain. The aim of this study was to investigate the effects of Cyperi rhizoma extract (CRE) on cell adhesion and the expression of pain-related factors (neurotrophins) in endometriotic cells, and to elucidate the underlying molecular mechanisms. CRE inhibited the adhesion of human endometriotic 12Z cells to peritoneal mesothelial Met5A cells using by adhesion assays. The mRNA expression of adhesion molecules [P-cadherin and matrix metalloproteinase (MMP)-2] was downregulated by CRE treatment. In addition, CRE significantly inhibited the mRNA expression of neurotrophins (BDNF, NGF, NT-3 and NT-4/5) in 12Z cells. Moreover, Akt overexpression markedly neutralized the inhibition of cell adhesion by CRE and expression of neurotrophins in 12Z cells. Furthermore, it was found that CRE suppressed NF-kB activation through the Akt pathway. These data suggest that CRE exerts anti-endometriotic activities by the inhibition of cell adhesion and neurotrophin expression, through the negative regulation of the Akt and NF-kB pathways in endometriotic cells.
This content is subject to copyright.


Citation: Ahn, J.-H.; Choi, J.-M.;
Kang, E.-S.; Yoo, J.-H.; Cho, Y.-J.;
Jang, D.S.; Choi, J.-H. The Anti-
Endometriotic Effect of Cyperi
Rhizoma Extract, Inhibiting Cell
Adhesion and the Expression of
Pain-Related Factors through Akt
and NF-kB Pathways. Medicina 2022,
58, 335. https://doi.org/10.3390/
medicina58030335
Academic Editor: Iveta Yotova
Received: 20 January 2022
Accepted: 19 February 2022
Published: 23 February 2022
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2022 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
medicina
Article
The Anti-Endometriotic Effect of Cyperi Rhizoma Extract,
Inhibiting Cell Adhesion and the Expression of Pain-Related
Factors through Akt and NF-kB Pathways
Ji-Hye Ahn 1, 2, * , Jun-Myeong Choi 2,3, Eun-Sol Kang 2, Jae-Hyeon Yoo 2, Yoon-Jin Cho 2, Dae Sik Jang 3
and Jung-Hye Choi 2, 3, *
1Department of Oriental Pharmacy, Woosuk University, Jeonju 55338, Korea
2Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University,
Seoul 02447, Korea; tkarjawhfh@gmail.com (J.-M.C.); amorfati8147@naver.com (E.-S.K.);
gaaon@hanmail.net (J.-H.Y.); cyjin422@khu.ac.kr (Y.-J.C.)
3Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Korea;
dsjang@khu.ac.kr
*Correspondence: jihyeahn20@woosuk.ac.kr (J.-H.A.); jchoi@khu.ac.kr (J.-H.C.);
Tel.: +82-63-290-1580 (J.-H.A.); +82-2-961-2172 (J.-H.C.);
Fax: +82-63-290-1576 (J.-H.A.); +82-2-961-9580 (J.-H.C.)
Abstract:
Rhizomes of Cyperus rotundus have been widely used as a traditional medicine in Asia for
the treatment of gynecological diseases. However, there is no scientific evidence demonstrating the
effect of C. rotundus rhizomes on endometriosis, which is characterized by the adhesion of endometrial
tissues outside the uterus, resulting in chronic and severe pelvic pain. The aim of this study was
to investigate the effects of Cyperi rhizoma extract (CRE) on cell adhesion and the expression of
pain-related factors (neurotrophins) in endometriotic cells, and to elucidate the underlying molecular
mechanisms. CRE inhibited the adhesion of human endometriotic 12Z cells to peritoneal mesothelial
Met5A cells using by adhesion assays. The mRNA expression of adhesion molecules [P-cadherin
and matrix metalloproteinase (MMP)-2] was downregulated by CRE treatment. In addition, CRE
significantly inhibited the mRNA expression of neurotrophins (BDNF, NGF, NT-3 and NT-4/5) in
12Z cells. Moreover, Akt overexpression markedly neutralized the inhibition of cell adhesion by CRE
and expression of neurotrophins in 12Z cells. Furthermore, it was found that CRE suppressed NF-kB
activation through the Akt pathway. These data suggest that CRE exerts anti-endometriotic activities
by the inhibition of cell adhesion and neurotrophin expression, through the negative regulation of
the Akt and NF-kB pathways in endometriotic cells.
Keywords: Cyperi rhizome; endometriosis; adhesion; neurotrophins; Akt; NF-kB
1. Introduction
Endometriosis is a chronic gynecological disease causing chronic pelvic pain, dys-
menorrhea, dyspareunia and infertility [
1
]. It is characterized by the presence and growth
of endometrial tissue outside the uterus in the peritoneal cavity. It affects approximately
6–10% of women of reproductive age and 30–50% of women with chronic pelvic pain [
2
].
Although the exact etiology of endometriosis remains unclear, retrograde menstruation
and implantation theories are widely accepted for endometriosis [24].
The adhesion of retrograde endometrial fragments onto the pelvic mesothelium is a
key step in the initiation of endometriosis formation [
5
]. Several adhesion molecules, includ-
ing P-cadherin (a predominant cadherin subtype) and matrix metalloproteinase-2 (MMP-2)
are upregulated in ectopic endometrial lesions, and have been suggested to be critical
factors in regulating the adhesion of ectopic endometrium to the peritoneal mesothelium
and/or extracellular matrix (ECM) [
6
,
7
]. Recently, an endometriotic implant surrounded
Medicina 2022,58, 335. https://doi.org/10.3390/medicina58030335 https://www.mdpi.com/journal/medicina
Medicina 2022,58, 335 2 of 14
by an inflammatory environment has also been reported to be involved in the genera-
tion of endometriosis-associated pelvic pain, by releasing pro-nociceptive mediators [
8
,
9
].
Emerging studies have demonstrated that neurotrophins, as a family of nerve growth
factors, including brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF),
neurotrophin-3 (NT-3) and neurotrophin-4/5 (NT-4/5), are observed in endometriotic
lesions, resulting in pelvic pain in endometriosis via neurogenic inflammation [10,11].
Cyperus rotundus Linn. (Cyperaceae), also known as “nut grass” or “purple nut sedge”
is a species of sedge native to Asia, southern and central Europe, and Africa, and it grows
naturally in tropical, sub-tropical and temperate regions [
12
]. In Asia, the rhizome of
C. rotundus (Cyperi rhizoma, CR) has been traditionally used as a herbal medicine for
the treatment of stomach and bowel disorders, bacterial infection and inflammatory dis-
eases [
13
]. In traditional Chinese medicine, CR is one of the oldest known medicinal
plants used for the treatment of dysmenorrhea, a symptom of endometriosis [
14
]. Modern
pharmacological studies have demonstrated that CR has several pharmacological and bio-
logical properties, including anti-inflammatory, anti-diabetic, anti-diarrheal, cytoprotective,
anti-microbial, anti-bacterial, anti-oxidant, anti-pyretic, anti-analgesic and neuroprotective
activities [
15
22
]. However, there is no scientific evidence demonstrating the effect of
CR on endometriosis, a chronic gynecological disease characterized by the growth and
adhesion of endometrial tissues outside the uterus, resulting in chronic and severe pelvic
pain [
23
,
24
]. In this study, we aimed to investigate the effects of Cyperi rhizoma extract
(CRE) on endometriosis, and to elucidate the underlying molecular mechanisms.
2. Materials and Methods
2.1. Plant Material and Preparation of the Extract
The rhizomes of Cyperus rotundus L. were obtained from a domestic Korean market
(Kyungdong Crude Drugs Market, Seoul, Korea) in June 2011. The origin of the herbal
material was identified by one of the authors (D.S. Jang), and a voucher specimen (CYRO1-
2011) was deposited in the lab of Natural Product Medicine, College of Pharmacy, Kyung
Hee University. The dried and milled plant material (2.8 kg) was extracted with 10 L of 80%
ethanol (EtOH) three times by maceration. The extract was combined and concentrated in
vacuo at 40
C to give an 80% EtOH extract (CRE; 399 g). For
in vitro
experiments, CRE
powder was dissolved in dimethyl sulfoxide (DMSO) (v/v) and filtered through a 0.22
µ
m
disk filter.
2.2. Materials
Dulbecco’s modified Eagle’s medium (DMEM)/F12 medium, Medium 199 (M199),
Opti-modified Eagle’s medium (Opti-MEM), fetal bovine serum (FBS), penicillin and
streptomycin were obtained from Life Technologies Inc. (Grand Island, NY, USA). Phos-
phate buffered saline (PBS), DMSO, RNase A, leupeptin, aprotinin and phenylmethyl-
sulfonylfluoride (PMSF) were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA).
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) was purchased from
Molecular Probes Inc. (Eugene, OR, USA). Antibodies against anti-phospho-Akt, anti-
phospho-IkB
α
and anti-phospho-IKK
α
/
β
were purchased from Cell Signaling Technology
(Beverly, MA, USA). The antibodies against anti-Akt, anti-p65, anti-IkB
α
, anti-IKK
α
/
β
,
anti-PARP and anti-ß-actin were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). CellTrackerTM was obtained from Invitrogen (Grand Island, NY, USA).
2.3. Cell Culture
Immortalized human endometriotic epithelial cells (12Z) were established from active
endometriotic lesions from women with endometriosis. In addition, the cell line displayed
the
in vivo
properties of the active phase of endometriosis as well as the phenotypic
characteristics [
25
]. The endometriotic 12Z cells were generously provided by Dr. Starzinski-
Powitz (Johann-Wolfgang-Goethe-Universitaet, Frankfurt, Germany) and maintained in
DMEM/F12 medium supplemented with 5% FBS, 100 U/mL penicillin and 100 mg/mL
Medicina 2022,58, 335 3 of 14
streptomycin (Life Technologies, Grand Island, NY, USA) in a humidified atmosphere of
5% CO
2
–95% air at 37
C. The human mesothelial cell line Met5A were originally from the
American Type Culture Collection. The cells were cultured in M199 supplemented with
10% FBS, penicillin (100 U/mL) and streptomycin sulfate (100 µg/mL).
2.4. Transfection
The pcDNA3-Akt-Myr (the constitutively active form of Akt) or the empty vector were
obtained from Addgene (Cambridge, MA, USA). After cells were cultured to
60–70%
con-
fluence, the cells were transfected with plasmid DNA constructs (2
µ
g/mL) by polyethylen-
imine (PEI) in serum-free OPTI-MEM (Invitrogen, CA, USA), according to the manufac-
turer’s instructions. After 24 h, the medium containing the DNA plasmids was replaced
with a fresh DMEM/F12 medium with 5% FBS, and the cells were treated with CRE.
2.5. Cell Viability Assay
Cell viability was assessed using an MTT assay. Briefly, human endometriotic cells
(12Z) were seeded at a density of 9
×
10
4
cells/mL in each well containing 50
µ
L of
DMEM/F12 medium in a 96-well plate. After 24 h, various concentrations of CRE were
added. After 24 h, 30
µ
L of MTT (1 mg/mL stock solution) was added, and the plates were
incubated for an additional 4 h. The medium was discarded, and the formazan blue, which
was formed in the cells, was dissolved in 50
µ
L DMSO. The optical density was measured at
540 nm using a microplate spectrophotometer (Spectra Max; Molecular Devices, Sunnyvale,
CA, USA).
2.6. Adhesion Assay
The mesothelial Met5A cells were grown to confluence on 96-well plates. Endometri-
otic cells were detached by trypsinization, washed with phosphate-buffered saline (PBS),
and probed with 10
µ
M CellTracker
TM
for 45 min at 37
C. CellTracker
TM
-labeled cells
were washed with a DMEM/F12 medium containing 0.1% FBS to remove the free dye, and
were added (2
×
10
4
cells/well) to the mesothelial cells. After incubation at 37
C for the
indicated time, the non-adherent cells were removed by gentle washing, the fluorescence
in each well was imaged, and the fluorescence was quantified in pixels using Scion Image
Software (Scion Corp, Frederick, MD, USA).
2.7. Nuclear Extraction
Cells were washed with PBS, scraped into 1 mL of ice-cold PBS, and pelleted by
centrifugation. The cell pellets were resuspended in hypotonic buffer (10 mM HEPES,
pH 7.9, 1.5 mM MgCl
2
, 10 mM KCl, 0.2 mM PMSF, 0.5 mM DTT, 10
µ
g/mL aprotinin) and
incubated on ice for 15 min. The cells were then lysed by adding 0.1% Nonidet P-40 and
vortexed vigorously for 10 s. Nuclei were pelleted by centrifugation at 12,000
×
gfor 1 min
at 4
C and resuspended in a high salt buffer (20 mM HEPES, pH 7.9, 25% glycerol, 400 mM
KCl, 1.5 mM MgCl
2
, 0.2 mM EDTA, 0.5 mM DTT, 1 mM NaF, 1 mM Sodium orthovanadate).
2.8. Western Blot Analysis
Cells were washed with ice-cold PBS and extracted in a protein lysis buffer (Intron
Biotechnology, Seoul, Korea). Protein concentrations were determined by the Bradford
assay. The cell lysates were mixed with 5 X SDS sample buffer, boiled for 4 min, and
then separated on 10% SDS-PAGE. After electrophoresis, proteins were transferred to
polyvinylidene difluoride membranes. The membranes were blocked in 2% bovine serum
albumin (BSA) for 30 min, washed, and incubated overnight at 4
C with specific primary
antibodies in Tris-buffered saline 2% BSA and 0.1% Tween-20 (TBS-T). The membranes
were washed three times to remove the primary antibodies and incubated for 2 h with a
horseradish peroxidase-conjugated secondary antibody (1:1000–2000). After washing three
times with TBS-T, immuno-positive bands were visualized using the ECL chemiluminescent
Medicina 2022,58, 335 4 of 14
system (Amersham Pharmacia Biotech, ON, Canada) and analyzed using ImageQuant
Las-4000 (GE Healthcare Life Science, WI, USA).
2.9. RNA Isolation and Real-Time RT–PCR Analysis
Total RNA was extracted from cells using the Easy Blue
®
kits (Intron Biotechnology,
Seoul, Korea), according to the manufacturer’s instructions. The total RNA was reverse
transcribed into first-strand cDNA (Amersham Pharmacia Biotech, ON, Canada) follow-
ing the manufacturer’s procedure. The synthesized cDNA was used as a template for
polymerase chain reaction (PCR) amplification. Real-time PCR was performed using the
Thermal cycler dice real-time PCR system (Takara, Japan). The primers used for SYBR
Green real-time RT-PCR were purchased from Bioneer technology (Daejon, Korea) and are
listed in Table S1. A dissociation curve analysis of P-cadherin, MMP-2, BDNF, NGF, NT-3,
NT-4/5, and GAPDH showed a single peak. PCRs were carried out for 45 cycles using
the following conditions: denaturation at 95
C for 5 s, annealing at 57
C for 10 s, and
elongation at 72
C for 20 s. The results for P-cadherin, MMP-2, BDNF, NGF, NT-3 and
NT-4/5 mRNA were normalized to a control gene GAPDH.
2.10. Statistical Analysis
All the data were expressed as mean
±
SD. The data obtained in experiments with
multiple treatments were subjected to one-way ANOVA analysis of variance followed by a
post hoc Tukey test of significance. Under all circumstances, p< 0.05 was considered to
be significant.
3. Results
3.1. Cyperi Rhizoma Extract Inhibits Endometriotic Cell Adhesion to Mesothelial Cells
Since the implantation of endometrial fragments at the peritoneum, which is covered
by a mesothelial cell layer, is a key step in the establishment of endometriosis [
24
,
26
], we
investigated the effect of CRE on the adhesion of endometriotic cells to mesothelial cells.
As shown in Figure 1A, pre-treatment of human endometriotic 12Z cells with CRE (25,
50, and 100
µ
g/mL) significantly reduced the adhesion of 12Z cells to human peritoneal
mesothelial Met5A cells. The inhibitory effect of CRE on the adhesion of 12Z cells to Met5A
cells was not attributed to cytotoxic effects when the endometriotic cells were exposed to
CRE up to 100
µ
g/mL for 24 h (Figure 1B). Furthermore, we investigated the expression of
P-cadherin and MMP-2, which have been well known as potent determinants in peritoneal
adhesion formation [
5
], after treatment with CRE in endometriotic 12Z cells. The results of
real-time RT-PCR showed that CRE at concentrations of 50 and 100
µ
g/mL significantly
decreased the mRNA expression of P-cadherin and MMP-2 in 12Z cells (Figure 1C).
3.2. Cyperi Rhizoma Extract Decreases the Expression of Neurotrophins in Human
Endometriotic Cells
Neurotrophins, such as BDNF, NGF, NT-3 and NT-4/5, are overexpressed in en-
dometriosis and are involved in the pathophysiology of pain generation in women with
endometriosis [
27
]. In this regard, we investigated whether CRE has an inhibitory effect on
the expression of neurotrophins in human endometriotic 12Z cells. When 12Z cells were
treated with CRE, the mRNA expression of BDNF, NGF, NT-3 and NT-4/5 was inhibited in
a dose-dependent manner (Figure 2). BDNF and NT-3 expression was markedly decreased
by CRE at concentrations of 25, 50 and 100
µ
g/mL. NGF expression was slightly reduced
by CRE stimulation at concentrations of 25, 50 and 100
µ
g/mL. NT-4/5 expression was
significantly inhibited only at the highest concentration tested (100
µ
g/mL). Consequently,
the highest dose (100
µ
g/mL) of CRE significantly inhibited the expression of all four tested
neurotrophins in this study in endometriotic 12Z cells.
Medicina 2022,58, 335 5 of 14
Medicina 2022, 58, x FOR PEER REVIEW 5 of 15
Figure 1. Effect of CRE on endometriotic cell adhesion to mesothelial cells and expression of
adhesion molecules in endometriotic cells. (A) Human endometriotic cells (12Z) were treated with
CRE at indicated concentration (25, 50 and 100 µg/mL) for 24 h. The 12Z cells labeled with
CellTracker
TM
(10 µM) were cultured on Met5A cell layers in a 96-well plate for 1 h. The total
fluorescence in each well was measured by fluorescence microphotography. (B) Cell viability was
determined by MTT assay. Representative images show the cell morphology of 12Z cells treated
with CRE at indicated concentration (25, 50 and 100 µg/mL) for 24 h. (C) The mRNA expression of
P-cadherin and MMP-2 was measured by real-time RT-PCR. All expression levels were normalized
to GAPDH. Results are the combined data (mean ± SD) from three independent experiments. * p <
0.05 compared with control group.
Figure 1.
Effect of CRE on endometriotic cell adhesion to mesothelial cells and expression of adhesion
molecules in endometriotic cells. (
A
) Human endometriotic cells (12Z) were treated with CRE at
indicated concentration (25, 50 and 100
µ
g/mL) for 24 h. The 12Z cells labeled with CellTracker
TM
(10
µ
M) were cultured on Met5A cell layers in a 96-well plate for 1 h. The total fluorescence in each
well was measured by fluorescence microphotography. (
B
) Cell viability was determined by MTT
assay. Representative images show the cell morphology of 12Z cells treated with CRE at indicated
concentration (25, 50 and 100
µ
g/mL) for 24 h. (
C
) The mRNA expression of P-cadherin and MMP-2
was measured by real-time RT-PCR. All expression levels were normalized to GAPDH. Results are
the combined data (mean
±
SD) from three independent experiments. * p< 0.05 compared with
control group.
Medicina 2022,58, 335 6 of 14
Medicina 2022, 58, x FOR PEER REVIEW 6 of 15
3.2. Cyperi Rhizoma Extract Decreases the Expression of Neurotrophins in Human
Endometriotic Cells
Neurotrophins, such as BDNF, NGF, NT-3 and NT-4/5, are overexpressed in
endometriosis and are involved in the pathophysiology of pain generation in women with
endometriosis [27]. In this regard, we investigated whether CRE has an inhibitory effect
on the expression of neurotrophins in human endometriotic 12Z cells. When 12Z cells
were treated with CRE, the mRNA expression of BDNF, NGF, NT-3 and NT-4/5 was
inhibited in a dose-dependent manner (Figure 2). BDNF and NT-3 expression was
markedly decreased by CRE at concentrations of 25, 50 and 100 µg/mL. NGF expression
was slightly reduced by CRE stimulation at concentrations of 25, 50 and 100 µg/mL. NT-
4/5 expression was significantly inhibited only at the highest concentration tested (100
µg/mL). Consequently, the highest dose (100 µg/mL) of CRE significantly inhibited the
expression of all four tested neurotrophins in this study in endometriotic 12Z cells.
Figure 2. Effect of CRE on the expression of neurotrophins in endometriotic cells. The 12Z cells were
treated with CRE (25, 50 and 100 µg/mL) for 24 h, and then the mRNA expression of neurotrophins
(BDNF, NGF, NT-3 and NT-4/5) was measured by real-time RT-PCR. All expression levels were
normalized to GAPDH. Results are the combined data (mean ± S.D.) from three independent
experiments. * p < 0.05 compared with control group.
3.3. The Akt Pathway Is Involved in Cyperi Rhizoma Extract-Induced Anti-Endometriotic
Effects in Human Endometriotic Cells
The Akt pathway is a critical regulator of cell adhesion and migration through the
regulation of actin organization and extracellular degradation [28]. Western blot analysis
demonstrated that CRE significantly decreased Akt phosphorylation in 12Z cells at 50 and
100 µg/mL. In addition, CRE treatment inhibited the Akt activation in a time-dependent
manner (Figure 3). To determine the involvement of the Akt pathway in the CRE-induced
anti-endometriotic effect, we performed a cell adhesion assay and real-time RT-PCR
analysis after transfection with a constitutively active form of Akt (Akt-Myr) in 12Z cells.
Figure 2.
Effect of CRE on the expression of neurotrophins in endometriotic cells. The 12Z cells were
treated with CRE (25, 50 and 100
µ
g/mL) for 24 h, and then the mRNA expression of neurotrophins
(BDNF, NGF, NT-3 and NT-4/5) was measured by real-time RT-PCR. All expression levels were
normalized to GAPDH. Results are the combined data (mean
±
S.D.) from three independent
experiments. * p< 0.05 compared with control group.
3.3. The Akt Pathway Is Involved in Cyperi Rhizoma Extract-Induced Anti-Endometriotic Effects
in Human Endometriotic Cells
The Akt pathway is a critical regulator of cell adhesion and migration through the
regulation of actin organization and extracellular degradation [
28
]. Western blot analysis
demonstrated that CRE significantly decreased Akt phosphorylation in 12Z cells at 50 and
100
µ
g/mL. In addition, CRE treatment inhibited the Akt activation in a time-dependent
manner (Figure 3). To determine the involvement of the Akt pathway in the CRE-induced
anti-endometriotic effect, we performed a cell adhesion assay and real-time RT-PCR analysis
after transfection with a constitutively active form of Akt (Akt-Myr) in 12Z cells. As shown
in Figure 4A,B, the overexpression of Akt partially reversed CRE-inhibited adhesion of 12Z
cells to Met5A cells as well as the expression of P-cadherin and MMP-2 in 12Z cells, which
was downregulated by CRE. In addition, the downregulation of neurotrophins by CRE
was significantly attenuated by Akt overexpression in 12Z cells (Figure 5). These results
suggested that CRE exerts anti-endometriotic effects through the downregulation of Akt
activation in endometriotic cells.
Medicina 2022,58, 335 7 of 14
Medicina 2022, 58, x FOR PEER REVIEW 7 of 15
As shown in Figure 4A,B, the overexpression of Akt partially reversed CRE-inhibited
adhesion of 12Z cells to Met5A cells as well as the expression of P-cadherin and MMP-2
in 12Z cells, which was downregulated by CRE. In addition, the downregulation of
neurotrophins by CRE was significantly attenuated by Akt overexpression in 12Z cells
(Figure 5). These results suggested that CRE exerts anti-endometriotic effects through the
downregulation of Akt activation in endometriotic cells.
Figure 3. Effect of CRE on the phosphorylation of Akt in endometriotic cells. 12Z cells were treated
with CRE (25, 50 and 100 µg/mL) for 2 h or with CRE (100 µg/mL) for 0.5, 1 and 2 h. Phosphorylated
Akt and total Akt were measured by western blot analysis using specific antibodies. β-Actin was
used as an internal control. Data are shown as mean band density. Data are presented as the means
± SD of three independent experiments; * p < 0.05 as compared with the control group.
Figure 3.
Effect of CRE on the phosphorylation of Akt in endometriotic cells. 12Z cells were treated
with CRE (25, 50 and 100
µ
g/mL) for 2 h or with CRE (100
µ
g/mL) for 0.5, 1 and 2 h. Phosphorylated
Akt and total Akt were measured by western blot analysis using specific antibodies.
β
-Actin was used
as an internal control. Data are shown as mean band density. Data are presented as the means
±
SD
of three independent experiments; * p< 0.05 as compared with the control group.
Medicina 2022, 58, x FOR PEER REVIEW 8 of 15
Figure 4. Involvement of the Akt pathway in endometriotic cell adhesion to mesothelial cells and
expression of adhesion molecules in endometriotic cells. 12Z cells were transfected with an empty
vector (EV) or a constitutive active form (Akt-Myr), and then the cells were treated with CRE (100
µg/mL). After 24 h, (A) an adhesion assay and (B) a real-time RT-PCR were performed. The mRNA
expression of P-cadherin and MMP-2 was normalized to GAPDH. * p < 0.05 compared with EV-
transfected none treatment group and
#
p < 0.05 compared with EV-transfected CRE treatment
group.
Figure 4. Cont.
Medicina 2022,58, 335 8 of 14
Medicina 2022, 58, x FOR PEER REVIEW 8 of 15
Figure 4. Involvement of the Akt pathway in endometriotic cell adhesion to mesothelial cells and
expression of adhesion molecules in endometriotic cells. 12Z cells were transfected with an empty
vector (EV) or a constitutive active form (Akt-Myr), and then the cells were treated with CRE (100
µg/mL). After 24 h, (A) an adhesion assay and (B) a real-time RT-PCR were performed. The mRNA
expression of P-cadherin and MMP-2 was normalized to GAPDH. * p < 0.05 compared with EV-
transfected none treatment group and
#
p < 0.05 compared with EV-transfected CRE treatment
group.
Figure 4.
Involvement of the Akt pathway in endometriotic cell adhesion to mesothelial cells and
expression of adhesion molecules in endometriotic cells. 12Z cells were transfected with an empty
vector (EV) or a constitutive active form (Akt-Myr), and then the cells were treated with CRE
(100
µ
g/mL). After 24 h, (
A
) an adhesion assay and (
B
) a real-time RT-PCR were performed. The
mRNA expression of P-cadherin and MMP-2 was normalized to GAPDH. * p< 0.05 compared with EV-
transfected none treatment group and
#
p< 0.05 compared with EV-transfected CRE treatment group.
Medicina 2022, 58, x FOR PEER REVIEW 9 of 15
Figure 5. Involvement of the Akt pathway in the expression of neurotrophins in endometriotic cells.
The 12Z cells were transfected with an empty vector (EV) or a constitutive active form (Akt-Myr),
and then the cells were treated with CRE (100 µg/mL). After 24 h, real-time RT-PCR was performed
to measure the mRNA expression of BDNF, NGF, NT-3 and NT-4/5. The expression levels were
normalized to GAPDH. * p < 0.05 compared with EV-transfected none treatment group and
#
p < 0.05
compared with EV-transfected CRE treatment group.
3.4. Cyperi Rhizoma Extract Inhibits NF-kB Activation through the Akt Pathway
Since NF-kB activation is implicated in the pathogenesis of endometriosis and an
endometriosis-associated pro-inflammatory environment [29], we examined the effect of
CRE on NF-kB activation in endometriotic 12Z cells. As shown in Figure 6A, CRE
markedly reduced the nuclear translocation of p65 NF-kB in 12Z cells. In addition, the
phosphorylation of both IkBα and IKKα/β, a key step in the modulation of NF-kB
activation, was inhibited by CRE treatment in 12Z cells. To examine the involvement of
Akt signaling in CRE-induced NF-kB inactivation in endometriotic cells further, we
performed western blot analysis after transfection with Akt-Myr in 12Z cells. As shown
in Figure 6B, NF-kB inactivation by CRE was reversed by Akt overexpression. In addition,
Akt overexpression could recover the decrease in phosphorylation of IkBα and IKKα/β in
the presence of CRE in 12Z cells. These results suggested that NF-kB inactivation by CRE
is mediated by the Akt pathway in endometriotic 12Z cells.
Figure 5.
Involvement of the Akt pathway in the expression of neurotrophins in endometriotic cells.
The 12Z cells were transfected with an empty vector (EV) or a constitutive active form (Akt-Myr),
and then the cells were treated with CRE (100
µ
g/mL). After 24 h, real-time RT-PCR was performed
to measure the mRNA expression of BDNF, NGF, NT-3 and NT-4/5. The expression levels were
normalized to GAPDH. * p< 0.05 compared with EV-transfected none treatment group and
#
p< 0.05
compared with EV-transfected CRE treatment group.
3.4. Cyperi Rhizoma Extract Inhibits NF-kB Activation through the Akt Pathway
Since NF-kB activation is implicated in the pathogenesis of endometriosis and an
endometriosis-associated pro-inflammatory environment [
29
], we examined the effect of
Medicina 2022,58, 335 9 of 14
CRE on NF-kB activation in endometriotic 12Z cells. As shown in Figure 6A, CRE markedly
reduced the nuclear translocation of p65 NF-kB in 12Z cells. In addition, the phosphory-
lation of both IkB
α
and IKK
α
/
β
, a key step in the modulation of NF-kB activation, was
inhibited by CRE treatment in 12Z cells. To examine the involvement of Akt signaling in
CRE-induced NF-kB inactivation in endometriotic cells further, we performed western
blot analysis after transfection with Akt-Myr in 12Z cells. As shown in Figure 6B, NF-kB
inactivation by CRE was reversed by Akt overexpression. In addition, Akt overexpression
could recover the decrease in phosphorylation of IkB
α
and IKK
α
/
β
in the presence of CRE
in 12Z cells. These results suggested that NF-kB inactivation by CRE is mediated by the
Akt pathway in endometriotic 12Z cells.
Figure 6.
Effect of CRE on the NF-kB activation in endometriotic cells. Nuclear (Nu) and whole
cellular proteins were isolated from the cells (
A
) treated with CRE (25, 50 and 100
µ
g/mL) for 8 h
and (
B
) transfected with EV or Akt-Myr. The levels of p65 (Nu), p-IkB
α
, IkB
α
, p-IKK
α
/
β
and
IKK
α
/
β
were detected by western blot analysis using specific antibodies. PARP and
β
-actin were
used as an internal control for nuclear fractions and whole cell lysates, respectively. Data are shown
as mean band density. Data are presented as the means
±
SD of three independent experiments;
*p< 0.05
as compared with the control group, and
#
p< 0.05 as compared with EV-transfected CRE
treatment group.
4. Discussion
The rhizomes of C. rotundus have been traditionally considered one of the most
important herbs for the treatment of obstetric/gynecologic disorders in Asia. In Vietnam
and Taiwan, the decoction of C. rotundus is used for treating infertility and dysmenorrhea in
women with endometriosis [
14
,
30
]. For example, Qi Gong Wan composed of various herbs
including Cyperi rhizoma relieves mid-cycle pain, vaginal discharge and adhesions [
14
].
Medicina 2022,58, 335 10 of 14
Although numerous experiences have been reported to show the effect of C. rotundus on
gynecologic disorders [
14
,
31
], there is little scientific evidence of the effect of C. rotundus
on gynecological diseases and the underlying molecular mechanisms of action. Choi et al.
examined the effect of water-extracted tubers of C. rotundus on endometrial receptivity
both
in vitro
and
in vivo
[
32
]. It was found that the water-extracted tubers of C. rotundus
enhanced the adhesion of trophoblastic JAr cells to endometrial cancer Ishikawa cells for
blastocyst implantation and improved the number of implantation sites in a mifepristone-
induced implantation failure mice model. In a recent retrospective cohort study using
the Taiwan National Health Insurance reimbursement database, the rate of endometriosis-
related surgery, including hysterectomy and oophorectomy, was significantly lower in
patients with endometriosis who took the traditional Chinese medicine formula Gui-zhi-
fu-ling-wan, which mainly comprises C. rotundus, than in patients with endometriosis
who did not take it [
33
]. Kim et al. has also demonstrated that Boheotang containing
Cyperi rhizoma has an inhibitory effect on recurrent endometriosis after laparoscopic
excision and hormone therapy [
34
]. However, to the best of our knowledge, there is no
direct experimental evidence supporting the effect of C. rotundus on endometriosis. In this
study, we investigated the effect of CRE on endometriosis using human endometriotic
12Z cells for the first time. The adhesive ability of endometriotic cells has been well
observed in endometriotic lesion formation [
26
]. In this study, we demonstrated that CRE
significantly inhibited the adhesion of endometriotic cells to peritoneal mesothelial cells,
without cytotoxicity.
Previous phytochemical reports revealed the presence of flavonoids, tannins, alkaloids,
glycosides, furochromones and sesquiterpenes in C. rotundus [
35
,
36
]. In fact, most of the
biological activities of the rhizomes of C. rotundus have been attributed to the sesquiter-
penes [
36
]. It is reported that isocyperol and
α
-cyperone, known as major sesquiterpene
components of the rhizomes of C. rotundus, have various pharmacological activities, such
as anti-inflammation, antivirulence, antigenotoxic, antibacterial and anti-depressant ef-
fects [
37
42
]. For example, isocyperol and
α
-cyperone have an inhibitory effect on in-
flammation through suppression of the NF-
κ
B pathway [
37
,
38
]. Zhang et al. showed the
inhibitory effects of
α
-cyperone on adhesion and invasion of avian pathogenic Escherichia
coli O78 to chicken type II pneumocytes [
43
]. However, to the best of our knowledge,
there is no evidence supporting the effect of active constituents of CRE in gynecologic
disorders including endometriosis. In a previous study, we found that
α
-cyperone is the
most abundant and active component of CRE [
44
47
]. In these regards, we have examined
the anti-endometriotic effect of
α
-cyperone in human endometriotic 12Z cells. Similar to
CRE,
α
-cyperone significantly inhibited the adhesive ability of 12Z cells to mesothelial
Met5A cells (Figure S1). This observation suggests a possibility that the anti-endometriotic
effects of CRE are mainly attributed to its major component,
α
-cyperone. However, further
experiments are still needed to draw this conclusion.
Cell surface proteins, including cadherin and MMPs, are expressed in the ectopic
endometrium and implicated in the regulation of cell-cell adhesion as well as cell-ECM
adhesion during the development of endometriosis [
5
]. Unlike E-cadherin and N-cadherin,
P-cadherin is found to be remarkably increased in peritoneal endometriotic lesions and di-
rectly involved in the interaction between endometrial cells and peritoneal cells [
6
]. MMP-2
is a collagenase-degrading collagen IV, the principal component of basement membranes,
and is significantly elevated in the urine of patients with endometriosis, compared to
healthy women [
48
]. A recent study demonstrated that physiological changes, including
adhesion, in endometriosis involve abnormal matrix remodeling, which is affected by
proteolytic enzymes, such as MMP-2 [
49
]. In addition, MMPs support the irreversible inac-
tivation of cadherin-catenin complexes [
50
]. In this study, we showed that CRE inhibited
the mRNA expression of P-cadherin and MMP-2 in endometriotic 12Z cells. These results
suggest that the downregulation of adhesion molecules, such as P-cadherin and MMP-2 by
CRE, may contribute to the inhibitory effect of CRE on the adhesion of endometriotic cells
to peritoneal mesothelial cells.
Medicina 2022,58, 335 11 of 14
Pelvic pain is one of the major symptoms in women with endometriosis, and is as-
sociated with the activation of nociceptive neurons [
51
]. It has been suggested that the
neurotrophins such as BDNF, NGF, NT-3 and NT-4/5 generate pelvic pain in endometriosis
by the direct alteration of neurological responsiveness, leading to hyperalgesia and allody-
nia stimuli [
1
]. A recent study demonstrated that the level of BDNF in circulation is found
to be elevated in women with endometriosis compared to healthy controls, and it decreased
after the surgical removal of lesions [
10
]. In addition, it has been reported in a recent study
that specific antibodies against neurotrophins, including NGF, may be used to treat and
prevent pain and symptoms associated with endometriosis [
52
]. In the present study, we
elucidated the inhibitory effect of CRE on the expression of BDNF, NGF, NT-3 and NT-4/5
in endometriotic cells. It was found that CRE significantly decreased the mRNA expression
of BDNF, NGF, NT-3 and NT-4/5 in 12Z cells. Taken together, CRE may have an inhibitory
effect on endometriosis-associated pain by modulating the expression of neurotrophins,
which is elevated in women with endometriosis.
The PI3K/Akt pathway is well known to regulate various cellular events, such as cell
growth, proliferation, apoptosis and differentiation stimulated by intra- and extracellular
signals [
53
]. Recently, the role of PI3K/Akt signaling in endometriosis has been impli-
cated. Yin et al. demonstrated that the over activation of the PI3K/Akt signaling pathway
contributes to the decrease in decidualization of stromal cells from endometriosis [
54
]. In
addition, rapid activation of PI3K/Akt mediated the growth factor- and estrogen-induced
migration of endometrial stromal cells [
55
]. Moreover, it has been suggested that the activa-
tion of Akt signaling is involved in the expression of P-cadherin and MMP-2 [
56
,
57
]. In the
present study, we found that the inhibitory effect of CRE on endometriotic cell adhesion and
neurotrophin expression in endometriotic cells is mediated by the Akt pathway. Notably, it
has been demonstrated that the activation of Akt affects the phosphorylation of IKK
β
and
the translocation of the NF-kB p65 subunit [
58
,
59
]. Many
in vitro
and
in vivo
evidences
show that the constitutive activation of NF-kB in endometriotic lesions from patients with
endometriosis promotes inflammation, cell proliferation, adhesion invasion and angio-
genesis in an endometriosis-associated pro-inflammatory environment [
60
63
]. In these
regards, we investigated the involvement of NF-kB activation in the effect of CRE on cell
adhesion and neurotrophin expression in endometriotic cells through the Akt pathway.
The results suggest that NF-kB signaling is likely to mediate the anti-endometriotic effect
of CRE through the Akt pathway.
5. Conclusions
In summary, we demonstrated the inhibitory effect of CRE on endometriosis via the
inhibition of cell adhesion and neurotrophin expression through negative regulation of Akt
and NF-kB pathways in human endometriotic cells.
These results provide scientific evidence that CRE could be a candidate for multidis-
ciplinary therapy, demonstrating a reduction of the adhesion of endometriotic fragments
and pain relief in patients with endometriosis. The
in vivo
effect of CRE on endometriosis
should be further investigated.
Supplementary Materials:
The following supporting information can be downloaded at: https:
//www.mdpi.com/article/10.3390/medicina58030335/s1, Figure S1: Effect of
α
-cyperone on en-
dometriotic cell adhesion to mesothelial cells, Table S1: Primer sequences for real-time RT-PCR
analysis, Supplementary Material and Methods: Preparation of the α-cyperone.
Author Contributions:
Conceptualization, J.-H.A. and J.-H.C.; formal analysis, J.-M.C., E.-S.K.,
J.-H.Y.
, Y.-J.C.; resources, D.S.J.; writing—original draft preparation, J.-H.A.; writing—review and
editing, J.-H.A. and J.-H.C.; supervision, J.-H.A. and J.-H.C. All authors have read and agreed to the
published version of the manuscript.
Funding:
This work has been supported by the National Research Foundation of Korea(NRF) grant
funded by the Korean government (MSIT) (NRF-2020R1I1A3073660).
Institutional Review Board Statement: Not applicable.
Medicina 2022,58, 335 12 of 14
Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Conflicts of Interest: The authors have declared no conflict of interest.
References
1. Burney, R.O.; Giudice, L.C. Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 2012,98, 511–519. [CrossRef]
2. Giudice, L.C.; Kao, L.C. Endometriosis. Lancet 2004,364, 1789–1799. [CrossRef]
3.
Czyzyk, A.; Podfigurna, A.; Szeliga, A.; Meczekalski, B. Update on endometriosis pathogenesis. Minerva Ginecol.
2017,69, 447–461
.
[CrossRef] [PubMed]
4.
Andres, M.P.; Arcoverde, F.V.L.; Souza, C.C.C.; Fernandes, L.F.C.; Abrao, M.S.; Kho, R.M. Extrapelvic Endometriosis: A Systematic
Review. J. Minim. Invasive Gynecol. 2020,27, 373–389. [CrossRef]
5.
Young, V.J.; Brown, J.K.; Saunders, P.T.; Horne, A.W. The role of the peritoneum in the pathogenesis of endometriosis. Hum.
Reprod. Update 2013,19, 558–569. [CrossRef]
6.
Chen, G.T.; Tai, C.T.; Yeh, L.S.; Yang, T.C.; Tsai, H.D. Identification of the cadherin subtypes present in the human peritoneum and
endometriotic lesions: Potential role for P-cadherin in the development of endometriosis. Mol. Reprod. Dev.
2002
,62, 289–294.
[CrossRef] [PubMed]
7.
Kim, J.H.; Yang, Y.I.; Ahn, J.H.; Lee, J.G.; Lee, K.T.; Choi, J.H. Deer (Cervus elaphus) antler extract suppresses adhesion and
migration of endometriotic cells and regulates MMP-2 and MMP-9 expression. J. Ethnopharmacol.
2012
,140, 391–397. [CrossRef]
8.
Morotti, M.; Vincent, K.; Becker, C.M. Mechanisms of pain in endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol.
2017
,209, 8–13.
[CrossRef]
9. Pezet, S.; McMahon, S.B. Neurotrophins: Mediators and modulators of pain. Annu. Rev. Neurosci. 2006,29, 507–538. [CrossRef]
10.
Wessels, J.M.; Kay, V.R.; Leyland, N.A.; Agarwal, S.K.; Foster, W.G. Assessing brain-derived neurotrophic factor as a novel clinical
marker of endometriosis. Fertil. Steril. 2016,105, 119–128.e5. [CrossRef]
11.
Streiter, S.; Fisch, B.; Sabbah, B.; Ao, A.; Abir, R. The importance of neuronal growth factors in the ovary. Mol. Hum. Reprod.
2016,22, 3–17. [CrossRef] [PubMed]
12.
Uddin, S.J.; Mondal, K.; Shilpi, J.A.; Rahman, M.T. Antidiarrhoeal activity of Cyperus rotundus.Fitoterapia
2006
,77, 134–136.
[CrossRef] [PubMed]
13.
Dang, G.K.; Parekar, R.R.; Kamat, S.K.; Scindia, A.M.; Rege, N.N. Antiinflammatory activity of Phyllanthus emblica, Plumbago
zeylanica and Cyperus rotundus in acute models of inflammation. Phytother. Res. 2011,25, 904–908. [CrossRef] [PubMed]
14.
Zhou, J.; Qu, F. Treating gynaecological disorders with traditional Chinese medicine: A review. Afr. J. Tradit. Complement. Altern.
Med. 2009,6, 494–517. [CrossRef] [PubMed]
15.
Gupta, M.B.; Palit, T.K.; Singh, N.; Bhargava, K.P. Pharmacological studies to isolate the active constituents from Cyperus rotundus
possessing anti-inflammatory, anti-pyretic and analgesic activities. Indian J. Med. Res. 1971,59, 76–82.
16.
Singh, P.; Khosa, R.L.; Mishra, G.; Jha, K.K. Antidiabetic activity of ethanolic extract of Cyperus rotundus rhizomes in streptozotocin-
induced diabetic mice. J. Pharm. Bioallied Sci. 2015,7, 289–292. [CrossRef]
17.
Seo, W.G.; Pae, H.O.; Oh, G.S.; Chai, K.Y.; Kwon, T.O.; Yun, Y.G.; Kim, N.Y.; Chung, H.T. Inhibitory effects of methanol extract
of Cyperus rotundus rhizomes on nitric oxide and superoxide productions by murine macrophage cell line, RAW 264.7 cells.
J. Ethnopharmacol. 2001,76, 59–64. [CrossRef]
18.
Ahn, J.H.; Lee, T.W.; Kim, K.H.; Byun, H.; Ryu, B.; Lee, K.T.; Jang, D.S.; Choi, J.H. 6-Acetoxy Cyperene, a Patchoulane-type
Sesquiterpene Isolated from Cyperus rotundus Rhizomes Induces Caspase-dependent Apoptosis in Human Ovarian Cancer Cells.
Phytother. Res. 2015,29, 1330–1338. [CrossRef]
19.
Zhu, M.; Luk, H.H.; Fung, H.S.; Luk, C.T. Cytoprotective effects of Cyperus rotundus against ethanol induced gastric ulceration in
rats. Phytother. Res. 1997,11, 392–394. [CrossRef]
20.
Kamala, A.; Middha, S.K.; Gopinath, C.; Sindhura, H.S.; Karigar, C.S.
In vitro
Antioxidant Potentials of Cyperus rotundus L.
Rhizome Extracts and Their Phytochemical Analysis. Pharmacogn. Mag. 2018,14, 261–267. [CrossRef]
21.
Mannarreddy, P.; Denis, M.; Munireddy, D.; Pandurangan, R.; Thangavelu, K.P.; Venkatesan, K. Cytotoxic effect of Cyperus
rotundus rhizome extract on human cancer cell lines. Biomed. Pharmacother. 2017,95, 1375–1387. [CrossRef]
22.
Jia, H.; Liu, Y.; Yu, M.; Shang, H.; Zhang, H.; Ma, L.; Zhang, T.; Zou, Z. Neuroprotective Effect of Cyperi rhizome against
Corticosterone-Induced PC12 Cell Injury via Suppression of Ca2+ Overloading. Metabolites 2019,9, 244. [CrossRef] [PubMed]
23. Jiang, L.; Yan, Y.; Liu, Z.; Wang, Y. Inflammation and endometriosis. Front. Biosci. 2016,21, 941–948.
24.
Saunders, P.T.K.; Horne, A.W. Endometriosis: Etiology, pathobiology, and therapeutic prospects. Cell
2021
,184, 2807–2824.
[CrossRef]
25.
Zeitvogel, A.; Baumann, R.; Starzinski-Powitz, A. Identification of an invasive, N-cadherin-expressing epithelial cell type in
endometriosis using a new cell culture model. Am. J. Pathol. 2001,159, 1839–1852. [CrossRef]
26.
Vercellini, P.; Vigano, P.; Somigliana, E.; Fedele, L. Endometriosis: Pathogenesis and treatment. Nat. Rev. Endocrinol.
2014,10, 261–275. [CrossRef] [PubMed]
27.
Kobayashi, H.; Yamada, Y.; Morioka, S.; Niiro, E.; Shigemitsu, A.; Ito, F. Mechanism of pain generation for endometriosis-
associated pelvic pain. Arch. Gynecol. Obstet. 2014,289, 13–21. [CrossRef] [PubMed]
Medicina 2022,58, 335 13 of 14
28.
Fabi, F.; Grenier, K.; Parent, S.; Adam, P.; Tardif, L.; Leblanc, V.; Asselin, E. Regulation of the PI3K/Akt pathway during
decidualization of endometrial stromal cells. PLoS ONE 2017,12, e0177387. [CrossRef] [PubMed]
29.
Gonzalez-Ramos, R.; Van Langendonckt, A.; Defrere, S.; Lousse, J.C.; Colette, S.; Devoto, L.; Donnez, J. Involvement of the nuclear
factor-kappaB pathway in the pathogenesis of endometriosis. Fertil. Steril. 2010,94, 1985–1994. [CrossRef] [PubMed]
30.
Hung, Y.C.; Kao, C.W.; Lin, C.C.; Liao, Y.N.; Wu, B.Y.; Hung, I.L.; Hu, W.L. Chinese Herbal Products for Female Infertility in
Taiwan: A Population-Based Cohort Study. Medicine 2016,95, e3075. [CrossRef] [PubMed]
31. Bhattarai, N.K. Folk herbal remedies for diarrhoea and dysentery in central Nepal. Fitoterapia 1993,64, 243–250. [CrossRef]
32.
Choi, H.J.; Chung, T.W.; Park, M.J.; Jung, Y.S.; Lee, S.O.; Kim, K.J.; Ha, K.T. Water-extracted tubers of Cyperus rotundus L. enhance
endometrial receptivity through leukemia inhibitory factor-mediated expression of integrin αVβ3 and αVβ5. J. Ethnopharmacol.
2017,208, 16–23. [CrossRef]
33.
Su, S.Y.; Muo, C.H.; Sung, F.C.; Morisky, D.E. Reduction of surgery rate in endometriosis patients who take Chinese medicine:
A population-based retrospective cohort study. Complement. Ther. Med. 2014,22, 632–639. [CrossRef]
34.
Kim, H.W.; Yoo, J.E. Inhibitory effect of traditional Korean medicine on the recurrent endometriosis after laparoscopic excision:
A case report. Integr. Med. Res. 2018,7, 296–301. [CrossRef]
35.
Xu, X.T.; Deng, Z.P.; Zhong, H.; Yao, Q.Q. Research progress on chemical constituents and pharmacological activities of
Cyperus rotundus L. Qilu Pharm. Aff. 2012,31, 473–475.
36.
Gamal, M.A.; Hani, K.M.K.; Sabrin, I.R.M. A Review: Compounds Isolated from Cyperus Species (Part II):Terpenoidal. Int. J.
Pharmacogn. Phytochem. Res. 2015,7, 83–99.
37.
Seo, Y.J.; Jeong, M.; Lee, K.T.; Jang, D.S.; Choi, J.H. Isocyperol, isolated from the rhizomes of Cyperus rotundus, inhibits LPS-induced
inflammatory responses via suppression of the NF-kappaB and STAT3 pathways and ROS stress in LPS-stimulated RAW 264.7
cells. Int. Immunopharmacol. 2016,38, 61–69. [CrossRef]
38.
Jung, S.H.; Kim, S.J.; Jun, B.G.; Lee, K.T.; Hong, S.P.; Oh, M.S.; Jang, D.S.; Choi, J.H. alpha-Cyperone, isolated from the rhizomes of
Cyperus rotundus, inhibits LPS-induced COX-2 expression and PGE2 production through the negative regulation of NFkappaB
signalling in RAW 264.7 cells. J. Ethnopharmacol. 2013,147, 208–214. [CrossRef]
39.
Luo, M.; Qiu, J.; Zhang, Y.; Wang, J.; Dong, J.; Li, H.; Leng, B.; Zhang, Q.; Dai, X.; Niu, X.; et al. alpha-cyperone alleviates
lung cell injury caused by Staphylococcus aureus via attenuation of alpha-hemolysin expression. J. Microbiol. Biotechnol.
2012,22, 1170–1176. [CrossRef]
40.
Singh, N.; Kulshrestha, V.K.; Gupta, M.B.; Bhargava, K.P. Apharmacological study of Cyperus rotundus.Indian J. Med. Res.
1970,58, 103–109.
41.
Jin, J.H.; Lee, D.U.; Kim, Y.S.; Kim, H.P. Anti-allergic activity of sesquiterpenes from the rhizomes of Cyperus rotundus.Arch.
Pharm. Res. 2011,34, 223–228. [CrossRef]
42.
Xia, B.; Tong, Y.; Xia, C.; Chen, C.; Shan, X. alpha-Cyperone Confers Antidepressant-Like Effects in Mice via Neuroplasticity
Enhancement by SIRT3/ROS Mediated NLRP3 Inflammasome Deactivation. Front. Pharmacol. 2020,11, 577062. [CrossRef]
43.
Zhang, L.Y.; Lv, S.; Wu, S.C.; Guo, X.; Xia, F.; Hu, X.R.; Song, Z.; Zhang, C.; Qin, Q.Q.; Fu, B.D.; et al. Inhibitory effects of
alpha-cyperone on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytes. Vet. Immunol.
Immunopathol. 2014,159, 50–57. [CrossRef]
44.
Kim, S.J.; Kim, H.J.; Kim, H.J.; Jang, Y.P.; Oh, M.S.; Jang, D.S. New patchoulane-type sesquiterpenes from the rhizomes of Cyperus
rotundus.Bull. Korean Chem. Soc. 2012,33, 3115–3118. [CrossRef]
45.
Kim, S.J.; Ryu, B.; Kim, H.-Y.; Yang, Y.-I.; Ham, J.; Choi, J.-H.; Jang, D.S. Sesquiterpenes from the rhizomes of Cyperus rotundus and
their potential to inhibit LPS-induced nitric oxide production. Bull. Korean Chem. Soc. 2013,34, 2207–2210. [CrossRef]
46.
Ryu, B.; Kim, H.M.; Lee, J.-S.; Cho, Y.J.; Oh, M.S.; Choi, J.-H.; Jang, D.S. Sesquiterpenes from rhizomes of Cyperus rotundus with
cytotoxic activities on human cancer cells in vitro. Helv. Chim. Acta 2015,98, 1372–1380. [CrossRef]
47.
Sim, Y.; Choi, J.G.; Gu, P.S.; Ryu, B.; Kim, J.H.; Kang, I.; Jang, D.S.; Oh, M.S. Identification of Neuroactive Constituents of the Ethyl
Acetate Fraction from Cyperi Rhizoma Using Bioactivity-Guided Fractionation. Biomol. Ther. 2016,24, 438–445. [CrossRef]
48.
Osteen, K.G.; Yeaman, G.R.; Bruner-Tran, K.L. Matrix metalloproteinases and endometriosis. Semin. Reprod. Med.
2003,21, 155–164. [CrossRef]
49.
Yang, W.V.; Au, H.K.; Chang, C.W.; Chen, H.W.; Chen, P.H.; Chen, C.C.; Tang, Y.L.; Wang, I.T.; Tzeng, C.R. Matrix remodeling and
endometriosis. Reprod. Med. Biol. 2005,4, 93–99. [CrossRef]
50.
Ribeiro, A.S.; Albergaria, A.; Sousa, B.; Correia, A.L.; Bracke, M.; Seruca, R.; Schmitt, F.C.; Paredes, J. Extracellular cleavage and
shedding of P-cadherin: A mechanism underlying the invasive behaviour of breast cancer cells. Oncogene
2010
,29, 392–402.
[CrossRef]
51.
Howard, F.M. Endometriosis and mechanisms of pelvic pain. J. Minim. Invasive Gynecol.
2009
,16, 540–550. [CrossRef] [PubMed]
52.
Howe, D.C.; Pullen, N.; Shelton, D.L. Treatment of Endometriosis. 2010. Available online: https://patents.google.com/patent/
WO2010029497A1/zh (accessed on 1 October 2020).
53.
Hennessy, B.T.; Smith, D.L.; Ram, P.T.; Lu, Y.; Mills, G.B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev.
Drug Discov. 2005,4, 988–1004. [CrossRef] [PubMed]
54.
Yin, X.; Pavone, M.E.; Lu, Z.; Wei, J.; Kim, J.J. Increased activation of the PI3K/AKT pathway compromises decidualization of
stromal cells from endometriosis. J. Clin. Endocrinol. Metab. 2012,97, E35–E43. [CrossRef]
Medicina 2022,58, 335 14 of 14
55.
Gentilini, D.; Busacca, M.; Di Francesco, S.; Vignali, M.; Vigano, P.; Di Blasio, A.M. PI3K/Akt and ERK1/2 signalling pathways
are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol. Hum. Reprod.
2007
,13, 317–322.
[CrossRef] [PubMed]
56.
Wang, X.; Li, X.; Li, C.; He, C.; Ren, B.; Deng, Q.; Gao, W.; Wang, B. Aurora-A modulates MMP-2 expression via AKT/NF-kappaB
pathway in esophageal squamous cell carcinoma cells. Acta Biochim. Biophys. Sin. 2016,48, 520–527. [CrossRef]
57.
Vieira, A.F.; Ribeiro, A.S.; Dionisio, M.R.; Sousa, B.; Nobre, A.R.; Albergaria, A.; Santiago-Gomez, A.; Mendes, N.; Gerhard, R.;
Schmitt, F.; et al. P-cadherin signals through the laminin receptor alpha6beta4 integrin to induce stem cell and invasive properties
in basal-like breast cancer cells. Oncotarget 2014,5, 679–692. [CrossRef]
58.
Ozes, O.N.; Mayo, L.D.; Gustin, J.A.; Pfeffer, S.R.; Pfeffer, L.M.; Donner, D.B. NF-kappaB activation by tumour necrosis factor
requires the Akt serine-threonine kinase. Nature 1999,401, 82–85. [CrossRef]
59.
Sizemore, N.; Leung, S.; Stark, G.R. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphoryla-
tion and activation of the NF-kappaB p65/RelA subunit. Mol. Cell. Biol. 1999,19, 4798–4805. [CrossRef]
60.
Cao, W.G.; Morin, M.; Sengers, V.; Metz, C.; Roger, T.; Maheux, R.; Akoum, A. Tumour necrosis factor-alpha up-regulates
macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB.
Hum. Reprod. 2006,21, 421–428. [CrossRef]
61.
Gonzalez-Ramos, R.; Donnez, J.; Defrere, S.; Leclercq, I.; Squifflet, J.; Lousse, J.C.; Van Langendonckt, A. Nuclear factor-kappa B is
constitutively activated in peritoneal endometriosis. Mol. Hum. Reprod. 2007,13, 503–509. [CrossRef]
62.
Gonzalez-Ramos, R.; Rocco, J.; Rojas, C.; Sovino, H.; Poch, A.; Kohen, P.; Alvarado-Diaz, C.; Devoto, L. Physiologic activation
of nuclear factor kappa-B in the endometrium during the menstrual cycle is altered in endometriosis patients. Fertil. Steril.
2012,97, 645–651. [CrossRef]
63.
Grund, E.M.; Kagan, D.; Tran, C.A.; Zeitvogel, A.; Starzinski-Powitz, A.; Nataraja, S.; Palmer, S.S. Tumor necrosis factor-alpha
regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB
in human endometriotic epithelial cells. Mol. Pharmacol. 2008,73, 1394–1404. [CrossRef] [PubMed]
... Human endometriotic epithelial cell line 11Z and 12Z [118] NF-κB inhibitor BAY 11-7085 Inhibits endometriotic cell proliferation via suppressing NF-κB signaling. hESCs isolated from patients with endometriosis [101] BAY 11-7085 and SN-50 Promotes the apoptosis of endometriosis-like lesions via suppressing NF-κB signaling. ...
... However, several studies also revealed that the role of NF-κB in endometrial epithelial cells shares several similarities with its role in endometrial stromal cells, such as the regulation by TNFα, estrogen signaling, and ncRNAs [24,31,61]; the promotion of cell proliferation, migration, invasion, and adhesion [56,73,74]; and the contribution to the resistance of ROS stress-induced cell apoptosis [56]. In addition, several drugs exert anti-endometriotic effects by downregulating NF-κB expression in endometrial epithelial cells [67,93,[117][118][119]. Figure 5. Potential interactions between drugs and key NF-κB signal-related genes, RELA and NFKB1. Drugs with an interaction score ≥ 0.2 were screened out. ...
Article
Full-text available
Endometriosis remains a common but challenging gynecological disease among reproductive-aged women with an unclear pathogenesis and limited therapeutic options. Numerous pieces of evidence suggest that NF-κB signaling, a major regulator of inflammatory responses, is overactive in endometriotic lesions and contributes to the onset, progression, and recurrence of endometriosis. Several factors, such as estrogen, progesterone, oxidative stress, and noncoding RNAs, can regulate NF-κB signaling in endometriosis. In the present review, we discuss the mechanisms by which these factors regulate NF-κB during endometriosis progression and provide an update on the role of NF-κB in affecting endometriotic cells, peritoneal macrophages (PMs) as well as endometriosis-related symptoms, such as pain and infertility. Furthermore, the preclinical drugs for blocking NF-κB signaling in endometriosis are summarized, including plant-derived medicines, NF-κB inhibitors, other known drugs, and the potential anti-NF-κB drugs predicted through the Drug-Gene Interaction Database. The present review discusses most of the studies concerning the multifaceted role of NF-κB signaling in endometriosis and provides a summary of NF-κB-targeted treatment in detail.
... Cyperi Rhizoma, known as Xiang-Fu in traditional Chinese medicine, has been prescribed more for helping with antidepressant activity [110]. Studies have also found that the Cyperi Rhizoma reduces the adhesion of endometriosis fragments and can be used for pain relief from endometriosis which may be experienced by PCOS patients [111]. ...
Article
Polycystic Ovary Syndrome (PCOS) is a prevalent hormonal disorder-affecting woman of reproductive age, marked by imbalances in hormones, insulin resistance, and metabolic irregularities. It manifests with symptoms such as irregular menstrual cycles, ovarian cysts, hirsutism, acne, and infertility. PCOS not only poses challenges to reproductive health but also elevates the risk of conditions like infertility, type 2 diabetes, and cardiovascular disease. Diagnoses encompass evaluating symptoms, hormonal profiles, and ovarian ultrasound results. The management of PCOS is designed to alleviate symptoms, restore hormonal equilibrium, and reduce associated health risks. PCOS is addressed through various systems of medicine, including lifestyle modifications, Allopathic or Western Medicine, Ayurvedic Medicine, Traditional Chinese Medicine (TCM), Persian Herbal Medicine, and Complementary and Alternative Medicine (CAM). Tailored to individual symptoms and health needs, these approaches aim to enhance the overall well-being of individuals with PCOS. Aspects of the mentioned systems of medicine can be combined to create personalized treatment plans that are the most effective in treating PCOS for unique patients.
... As a result, this medicinal plant inhibited cell adhesion and neutrophin expression by negatively affecting Akt and NF-kB pathways in endometriotic cells. Thus, the inhibitory effect of Cyperus rotundus on endometriosis has been demonstrated(Ahn et al., 2022). ...
Chapter
Full-text available
ZYAZICI ve Doç. Dr. Esra UÇAR'ın yapacağı Ziraat, Orman ve Su Ürünü alanlarında özgün çalışmalar içeren "DIFFERENT PERSPECTIVES IN MEDICINAL AND AROMATIC PLANTS" adlı kitapta yayınlanmaya uygun görülmüştür. Uluslararası olarak yayınlanacak olan kitap çalışmamızda bölümünüzün yer almasını düşünmekteyiz. Çalışmalarınızda başarılar dileriz.
... 18,[29][30][31][32] Researchers have shown that NGF and P75 are overexpressed in patients with endometriosis compared to those without endometriosis, suggesting that these factors are involved in disease pathogenesis. [33][34][35] We previously observed that YKYTP can suppress NGF and P75 expression in the rat model of adenomyosis. 23 In this study, we set out to investigate whether YKYTP regulates ER expression in MCs and neurons. ...
Article
Full-text available
Background Previously, we showed that Yikun Yitong Ping (YKYTP) can effectively and safely relieve endometriosis-related dysmenorrhea; however, the underlying mechanism remained unclear. This study aimed to assess the effects of YKYTP-containing serum on rat basophilic leukemia cell line, as mast cells (MCs) analog, and investigate the mechanisms by which YKYTP alleviates endometriosis-related dysmenorrhea. Method In this study, YKYTP drug-containing serum was used to treat rat basophilic leukemia cell line (RBL2H3). The effect of YKYTP-containing serum on the expression of ER-α, ER-β, NGF, and NGFRp75 in RBL2H3 cells was evaluated using enzyme-linked immunosorbent assay, quantitative real-time polymerase reaction, and Western blotting. Results Different concentrations (5%-40%) of YKYTP-containing serum reduced ER expression in RBL2H3 cells, and the optimum concentration was 40%. Compared to the blank group, the expression of ER and NGF significantly increased in the E2 group (P < .01). After co-administration with YKYTP-containing serum, the expression of ER-α, ER-β, NGF, and P75 significantly decreased (P < .01). Conclusion YKYTP-containing serum can efficiently inhibit the expression of ER-α, ER-β, NGF, and P75 in RBL2H3 cells. YKYTP may alleviate endometriosis-related dysmenorrhea by downregulating ER expression in MCs.
Article
Full-text available
Endometritis is a common inflammatory condition of the uterine endometrial lining that primarily affects perinatal dairy animals and causes significant economic losses in agriculture. It is usually triggered by pathogenic bacteria and is associated with chronic postpartum reproductive tract infections. Bacterial lipopolysaccharides (LPSs) are known to increase levels of reactive oxygen species (ROS), leading to oxidative stress and inflammation through the activation of the NF-κB signaling pathway and the inhibition of Nrf2 nuclear translocation, which regulates antioxidant response elements (AREs). The effectiveness of the conventional management strategy involving antibiotics is decreasing due to resistance and residual concerns. This review explores the potential therapeutic benefits of targeting the Nrf2/Kelch-like ECH-associated protein 1 (Keap1)/NF-κB signaling pathway to alleviate LPS-induced endometritis. We discuss recent advancements in veterinary medicine that utilize exogenous antioxidants to modulate these pathways, thereby reducing oxidative stress and inflammatory responses in endometrial cells. This review highlights the efficacy of several bioactive compounds that enhance Nrf2 signaling and suppress NF-κB activation, offering protective effects against oxidative damage and inflammation. By examining various in vitro studies, this review emphasizes the emerging role of these signaling pathways in developing new therapeutic strategies that could potentially replace or supplement traditional treatments and mitigate the economic impacts of endometritis in livestock.
Article
Full-text available
Endometriosis (EMS) is defined as the appearance, growth, infiltration, and repeated bleeding of endometrioid tissue (glands and stroma) outside the uterus cavity, which can form nodules and masses. Endometriosis is a chronic inflammatory estrogen-dependent disease and occurs in women of reproductive age. This disorder may significantly affect the quality of life of patients. The pathogenic processes involved in the development and maintenance of endometriosis remain unclear. Current treatment options for endometriosis mainly include drug therapy and surgery. Drug therapy mainly ties to the use of non-steroidal anti-inflammatory drugs (NSAIDs) and hormonal drugs. However, these drugs may produce adverse effects when used for long-term treatment of endometriosis, such as nausea, vomiting gastrointestinal reactions, abnormal liver and kidney function, gastric ulcers, and thrombosis. Although endometriosis lesions can be surgically removed, the disease has a high recurrence rate after surgical resection, with a recurrence rate of 21.5% within 2 years and 40% to 50% within 5 years. Thus, there is an urgent need to develop alternative or additional therapies for the treatment of endometriosis. In this review, we give a systematic summary of therapeutic multiple component prescriptions (including traditional Chinese medicine and so on), bioactive crude extracts of plants/herbs and purified compounds and their newly found mechanisms reported in literature in recent years against endometriosis.
Article
Full-text available
Cyperi Rhizoma (CR) is the dry rhizome of Cyperus rotundus L., a Cyperaceae plant. It has a long history of clinical medication and is known as the “holy medicine” of gynecology. CR smells sweet and bitter. It has the effect of soothing the liver and relieving depression, regulating qi, regulating meridian and relieving pain. It can be used to treat liver qi stagnation, chest pain, spleen and stomach qi stagnation, hernia pain, irregular menstruation and other diseases. At present, the main chemical constituents isolated from CR are volatile oil, flavonoids and terpenes. Modern pharmacological studies have shown that CR has a wide range of pharmacological activities, including antidepressant, hypoglycemic, antioxidant, anti-inflammatory, antipyretic and analgesic effects. In this paper, the botany, traditional application, phytochemistry, pharmacological effects, processing and other aspects of CR are reviewed. At the same time, the shortcomings of current research of CR are discussed in depth, and the possible solutions are put forward in order to find a breakthrough point for future research of CR.
Article
Full-text available
α-Cyperone (Cy) is a major active compound of Cyperus rotundus that has various pharmacological activities. But whether Cy possesses antidepressant effect is unknown. In this study, we exposed mice to chronic unpredictable mild stress (CUMS) with or without intervention with Cy. Our results showed that Cy significantly improved the depressive phenotypes in sucrose preference test, tail suspension test and forced swimming test. Meanwhile, increased SIRT3 expression, reduced ROS production and activated NF-κB signal were detected in the hippocampus of mice. NLRP3 inflammasome related proteins including NLRP3, ASC, Caspase-1, IL-1β, IL-18 and GSDMD-N were downregulated after Cy administration. Synaptic proteins including Synapsin-1 and PSD-95 and dendritic spine density were improved after Cy treatment. Moreover, the protective effects of Cy in CUMS mice were compromised when co-administrated with SIRT3 inhibitor 3-TYP. Taken together, these findings suggested that Cy has therapeutic potential for treating depression and that this antidepressant effect may be attributed to SIRT3 stimulated neuroplasticity enhancement by suppressing NLRP3 inflammasome.
Article
Full-text available
Cyperi Rhizoma (CR) is a well-known functional food and traditional herbal medicine in Asian countries for the treatment of menstrual or emotional disturbances in women. Recent studies have shown the pharmacological effects of CR on neuronal diseases, such as Parkinson’s disease (PD) and depression. Thus, the neuroprotective effect of CR might play a vital role in exerting its effect. Here, corticosterone-induced PC12 cells were applied to screen the active fraction of CR and evaluate its neuroprotective effect. The results indicated that the fraction containing medium-polarity chemical constituents (CR-50E) displayed the best protection effect. CR-50E could increase the cell viability and reduce cell apoptosis through inhibiting oxidative stress and decreasing the lactate dehydrogenase LDH release induced by corticosterone. Further, the mechanism of action was explored by cell metabolomics. The result showed CR-50E mediated the sphingolipids metabolism of corticosterone-induced PC12 cells, which suggested inhibition of Ca²⁺ overloading may involve the protection of CR-50E against cell damage. The expression levels of three key proteins in calcium transport, including phospholipase A2 (PLA2), calcium/calmodulin independent protein kinase II (CaMK II), and caspase-3, confirmed the above result by Western blot. The findings suggest that CR-50E can suppress the disequilibrium of calcium homeostasis-mediated apoptosis by improving the abnormal sphingolipids metabolism as well as remedying the damage of the cell membrane.
Article
Full-text available
Endometriosis is a common benign gynecologic tumor, and it can destroy a patient's life. Surgery and hormone therapy are established therapies for endometriosis. However, there are many cases of recurrent endometriosis after conventional therapies. This report presents a case of a patient who has repetitive recurrence of endometriosis after laparoscopic excision and hormone therapy. A 32-years-old female patient first had laparoscopic surgery to remove endometriosis in 2011. The disease recurred two more times after the first excision. Hormone therapy by dienogest and two more laparoscopic surgeries were done in 2012 and 2014. With acupuncture, moxibustion, fumigation therapy, and herbal medicine therapy, endometriosis didn’t recur during treatment and observation period of 34 months. Menstrual pain numeric rating scales (NRS) decreased from 2 to none. Shortened menstrual cycle (24 days) after second surgery became longer (26.63 ± 2.28 days) after traditional Korean medicine therapy. This case presents the therapeutic potential of TKM for inhibitory effect on the recurrent endometriosis after laparoscopic excision and hormone therapy.
Article
Full-text available
Background Cyperus rotundus L. (family Cyperaceae), native to India, is a multivalent medicinal plant widely used in conventional medicine. The research reports on bioactive components from C. rotundus L. are scanty. Objective The objective of the study was to optimize the best solvent system and bioprospect the possible phytochemicals in C. rotundus L. rhizome (CRR). Materials and Methods The phytochemicals were extracted from the rhizomes of C. rotundus L. by successive Soxhlet technique with solvents of increasing polarity. The resultant extracts were analyzed for their total flavonoid content (TFC), total phenolic content (TPC), total proanthocyanidin content (TPAC), in vitro antioxidant potential, and inhibition of lipid peroxidation. The 70% acetone extract of CRR was analyzed using gas chromatography–mass spectrometry (GC-MS) for probable phytochemicals. Results and Discussion The TPC, TFC, and TPAC estimates ranged from 0.036 ± 0.002 to 118.924 ± 5.946 μg/mg extract, 7.196 ± 0.359 to 200.654 ± 10.032 μg/mg extract, and 13.115 ± 0.656 to 45.901 ± 2.295 μg/mg extract, respectively. The quantities of TPC, TFC, and TPAC were found to be the highest in 70% acetone extract. The 70% acetone and 70% methanol extracts revealed best radical scavenging effect. GC-MS analysis of CRR extract revealed the presence of a novel compound 1 (2)-acetyl-3 (5)-styryl-5 (3)-methylthiopyrazole. Conclusion The study indicated that 70% acetone and 70% methanol extracts of CRRs can be a potential source of antioxidants. SUMMARY The studies suggest 70% methanol and acetone as the suitable solvents for the extraction of phytochemicals Novel compound 1(2)-Acetyl-3(5)-styryl-5(3)-methylthiopyrazole was detected in 70% acetone extract. Abbreviations used: ACRE: Acetone C. rotundus L. rhizome extract; AlCl3: Aluminum chloride; AQRE: Aqueous C. rotundus L. rhizome extract; CE: Catechin Equivalent; CHRE: Chloroform C. rotundus L. rhizome extract; CRR: C. rotundus L. rhizome; DPPH: 2,2 diphenyl-1-picrylhydrazyl; ETRE: Ethanolic C. rotundus L. rhizome extract; EARE: Ethyl acetate C. rotundus L. rhizome extract; FRP: Ferric reducing power; GAE: Gallic acid equivalent; GC-MS: Gas chromatography-mass spectrometry; HERE: Hexane C. rotundus L. rhizome extract; MERE: Methanolic C. rotundus L. rhizome extract; PERE: Petroleum ether C. rotundus L. rhizome extract; QE: Quercetin equivalent; RNS: Reactive nitrogen species; ROS: Reactive oxygen species; TFC: Total flavonoid content; TPC: Total phenolic content; TPAC: Total proanthocyanidin content.
Article
Full-text available
Infertility is constantly increasing in Canada, where 16% of Canadian couples are experiencing difficulty conceiving. It is thought that infertility can emanate from the dysregulated communication between the embryo and the maternal endometrium. In order to allow for this window of implantation to be open at the right moment, endometrial stromal cells proliferate and differentiate by a mechanism called decidualization. Intracellular and molecular mechanisms involved in the regulation of apoptosis and cell proliferation during decidualization of the endometrium are yet to be fully understood. It has been well demonstrated previously that Akt is importantly involved in cell survival and glycogen synthesis. Akt1, Akt2 and Akt3 isoforms have distinct physiological roles; this could also be the case during decidualization and pregnancy. The aim of this study is to investigate the regulation of PI3K/Akt pathway during the decidualization process of endometrial stromal cells. Expression of Akt isoforms, Akt activity (phospho-Akt), pIκB and substrates of Akt during decidualization were measured. To our knowledge, these results are the first to suggest a decrease in levels of Akt isoforms as well as a downregulation of Akt activity in the process of decidualization of human endometrial stromal cells. We also uncovered that decidualization induced nuclear localization of p65 through the phosphorylation of IκB, its inhibitory subunit; however, Par-4, a recently uncovered regulator of cell differentiation, was displaced from the nucleus upon decidualization. Our results also suggest that HIESC cells exhibit decreased motility during decidualization and that PI3K pathway inhibition could be involved in this process. Finally, we demonstrate that specific Akt isoforms present unique effects on the successful induction of decidualization. Further analyses will involve investigations to understand the precise signaling mechanisms by which this pathway is regulated.
Article
Endometriosis is a common condition associated with infertility that causes chronic pain in many, but not all, women. It is defined by the presence of endometrial-like tissue outside the uterus. Although the cause and natural history of the disorder remain uncertain, hormonal, neurological, and immunological factors are all implicated in the mechanisms contributing to development of symptoms. Because definitive diagnosis requires surgery, there is often a long diagnostic delay after onset of symptoms. Current interventions for endometriosis have limited efficacy and unacceptable side effects/risks and are associated with high rates of symptom recurrence. Here, we review recent advances in our understanding of the etiology of endometriosis, discuss current diagnostic and treatment strategies, highlight current clinical trials, and consider how recent results offer new avenues for the identification of endometriosis biomarkers and the development of effective non-surgical therapies that are fertility-sparing.
Article
Objective: To conduct a systematic review of the literature for patients with extra-pelvic deep endometriosis. Data source: A thorough search was performed through PubMed/MEDLINE, EMBASE and Cochrane databases. Methods of study selection: Following PRISMA guidelines, in the last 20 years that reported on primary extra-pelvic endometriosis were included (PROSPERO registration number CRD42019125370). Tabulation and integration: Initial search identified 5.465 studies and 179 studies, mostly case reports and series, were included. A total of 230 parietal (PE), 43 visceral (VE), 628 thoracic (TE), 6 central nerve system (CNS), 12 extra-pelvic muscle or nerves, and one nasal endometriosis papers were identified. Results: Abdominal endometriosis was divided into PE and VE. PE lesions involved primary lesions of the abdominal wall, groin and perineum where presenting symptoms were palpable mass (99%), cyclic pain (71%) and cyclic bleeding (48%). Pre-operative clinical suspicion was low and use of tissue diagnosis was indeterminate (25%), and a few (8%) malignancy suspected. Surgical treatment for PE included wide local excision (97%) with 5% recurrence and no complications. Patients with VE involving the abdominal organs - kidneys, liver, pancreas, biliary tract - were treated surgically (86%) with both conservative (51%) and radical resection (49%), with 15% recurrence and 2 major complications reported. In patients with TE involving the diaphragm, pleura and lung, isolated and concomitant lesions occurred and favored the right side (80%). Patients with TE presented with triad of catamenial pain, pneumothorax and hemoptysis. Thoracoscopic with resection followed by pleurodesis were the most common procedures performed with 29% recurrence. Adjuvant medical therapy with GnRH was used in 15% of cases. Preoperative imaging with MRI was used in all cases of non-thoracic and non-abdominal endometriosis. Common symptoms were paresthesia and cyclic pain with radiation. Surgical resection was reported in 84% with improvement of symptoms. Conclusions: Extra-pelvic endometriosis, traditionally thought to be rare, have been reported in a considerable number of cases. Heightened awareness and clinical suspicion of the disease, and multi-disciplinary approach is recommended to achieve prompt diagnosis and optimize patient outcomes. At this time, there are no comparative studies to provide recommendations regarding optimal diagnostic methods, treatment options and outcomes for endometriosis involving extra-pelvic sites.
Article
The wild weed Cyperus rotundus is commonly used as traditional medicine in different parts of the world. Sequential extraction of C. rotundus rhizome with solvents of different polarity namely hexane, chloroform, ethyl acetate, methanol and water were prepared and the free radical scavenging activity was determined by 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. Based on high antioxidant activity of methanolic extract of C. rotundus rhizome (MRCr) was further investigated for its cytotoxic effect on different human cancer cell lines-breast (MCF-7), cervical (HeLa), liver (Hep G2), prostate (PC-3), colorectal (HT-29) and normal cell line (MCF-12A) by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay evaluated as 50% inhibition of growth (IC50). Apoptosis cells were analysed by flow cytometry stained with annexin V-Fluorescein isothiocyanate conjugate (AF) and propidium iodide (PI). The cellular and nuclear changes were examined under light and fluorescent microscope using 4', 6' diamino-2-phenylindole (DAPI) stain, dual stains of AF/PI and acridine orange/ethidium bromide (AO/EB). The cytotoxic effects on the tested cancer cell lines ranged from 4.52±0.57 to 9.85±0.68μgml(-1). The migration assay was showed the inhibitory effect with MRCr. The MRCr showed significant anticancer activity against all the tested cancer cell lines and also protected the non-cancer cells. The anticancer activity suggests further elucidation for the formulation of natural pharmaceutical products in the treatment of cancer.
Article
Ethnopharmacological relevance: Cyperus rotundus L. (CR) has been traditionally used as an herbal medicine in Asian countries to treat diverse gynecological disorders. However, the potential therapeutic effect of CR on endometrial receptivity for successful embryo implantation to treat female infertility has not been fully studied. Aim of study: The aim of this study was to evaluate the effect of water-extracted CR on endometrial receptivity by investigating the expression of leukemia inhibitory factor (LIF) and integrins, cell adhesion, and embryo implantation using mifepristone (RU486; RU)-induced implantation failure model. Materials and methods: The water extract of CR was prepared and fingerprinted using high-performance liquid chromatography (HPLC). For the expression and regulation of LIF, reverse transcription polymerase chain reaction (RT-PCR) and western blotting were performed in CR-stimulated Ishikawa cells. To evaluate LIF-mediated integrin expression, knockdown of LIF by shRNA was performed in Ishikawa cells. The effect of CR on endometrial receptivity was determined by an in vitro adhesion assay between JAr cells and CR-induced Ishikawa cells. In vivo, C57BL/6 female mice (n = 7 per group) orally received CR (31.68mg/kg/day), a similar dose as used clinically. Seven days after CR treatment, all female mice were caged with male mice until pregnancy was verified. On day 4 of pregnancy, RU (4mg/kg) was injected subcutaneously to induce embryo implantation failure. Result: CR increased the expression of LIF through the phosphatidylinositol-3-kinase/ protein kinase B (PI-3K/AKT) signaling pathway in Ishikawa cells. In addition, CR enhanced adhesion of JAr cells onto Ishikawa cells by inducing the expression of LIF-dependent integrins αVβ3 and αVβ5. Furthermore, CR improved the number of implantation sites in pregnant mice despite RU injection. Conclusion: CR increased the expression of LIF-mediated integrins αVβ3 and αVβ5 on the surface of endometrial cells, which is associated with adhesion of trophoblastic cells to endometrial cells for blastocyst implantation. Our findings provide evidence that CR has therapeutic potential against poor endometrial receptivity.
Article
Endometriosis is a chronic, inflammatory, condition of high incidence and serious reproductive and general health consequences. Understanding the pathogenesis of endometriosis is crucial for proper diagnostic and ordering the most effective treatment. Even though there is a large body of data regarding this pathology our understanding of the pathogenesis of this disease remains incomplete. The aim of this review is to summarize contemporary data regarding pathogenesis of endometriosis. Current data regarding endometrial origin, metaplastic and Mullerian embryonic rests theory will be reviewed here. Also genetic, epigenetic, environmental factors and immunological dysfunction role in endometriosis will be summarized. To conclude a lot of effort must be put to integrate the abundant data from genetic, epigenetic and immunological studies to propose one coherent theory for the pathogenesis of endometriosis.